Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Quest Diagnostics
  6. Summary
    DGX   US74834L1008

QUEST DIAGNOSTICS

(DGX)
  Report
Delayed Nyse  -  04:03 2022-06-24 pm EDT
140.31 USD   +2.10%
06/24Quest Diagnostics to Release Second Quarter 2022 Financial Results on July 21, 2022
PR
06/24QUEST DIAGNOSTICS INCORPORATED(NYSE : DGX) added to Russell 1000 Dynamic Index
CI
06/14QUEST DIAGNOSTICS : Names Sam Samad Executive Vice President and Chief Financial Officer - Form 8-K
PU
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/17/2022 06/21/2022 06/22/2022 06/23/2022 06/24/2022 Date
130.64(c) 131.93(c) 134.34(c) 137.42(c) 140.31(c) Last
1 764 487 859 537 850 072 915 275 995 065 Volume
+2.08% +0.99% +1.83% +2.29% +2.10% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 9 346 M - -
Net income 2022 1 058 M - -
Net Debt 2022 2 995 M - -
P/E ratio 2022 16,4x
Yield 2022 1,83%
Sales 2023 9 092 M - -
Net income 2023 946 M - -
Net Debt 2023 2 790 M - -
P/E ratio 2023 18,3x
Yield 2023 1,93%
Capitalization 16 467 M 16 467 M -
EV / Sales 2022 2,08x
EV / Sales 2023 2,12x
Nbr of Employees 44 500
Free-Float 71,6%
More Financials
Company
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows: - testing and diagnostic services (96.8%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services; - other (3.2%). 
Read more
More about the company
Ratings of Quest Diagnostics
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about QUEST DIAGNOSTICS
06/24Quest Diagnostics to Release Second Quarter 2022 Financial Results on July 21, 2022
PR
06/24QUEST DIAGNOSTICS INCORPORATED(NYSE : DGX) added to Russell 1000 Dynamic Index
CI
06/14QUEST DIAGNOSTICS : Names Sam Samad Executive Vice President and Chief Financial Officer -..
PU
06/14QUEST DIAGNOSTICS INC : Change in Directors or Principal Officers, Regulation FD Disclosur..
AQ
06/14Pack Health Named Best Wellness Platform at Future Digital Awards by Juniper Research
PR
06/13New Quest Diagnostics Health Trends Study, in Collaboration with Cdc, Shows Less Than H..
CI
06/10Illumina Shares Drop Following News of CFO Departure
MT
06/10TRANSCRIPT : Quest Diagnostics Incorporated Presents at 2022 Jefferies Global Healthcare C..
CI
06/09Quest Diagnostics Appoints Sam Samad CFO
MT
06/09Quest Diagnostics Incorporated Names Sam Samad as Executive Vice President with Effect ..
CI
06/09Quest Diagnostics Incorporated Names Sam Samad as Chief Financial Officer with Effect f..
CI
06/08QUEST DIAGNOSTICS : Media Statement about COVID-19 Testing
PU
05/26Quest Diagnostics to Speak at the Jefferies Healthcare Conference
PR
05/25INSIDER SELL : Quest Diagnostics
MT
05/25QUEST DIAGNOSTICS : Management Change/Compensation - Form 8-K
PU
More news
News in other languages on QUEST DIAGNOSTICS
06/13Une nouvelle étude de Quest Diagnostics sur les tendances en matière de santé, en colla..
06/10Les actions d'Illumina chutent après l'annonce du départ du directeur financier
06/09Quest Diagnostics nomme Sam Samad au poste de directeur financier
06/09Quest Diagnostics Incorporated nomme Sam Samad au poste de vice-président exécutif à co..
05/25Quest Diagnostics Incorporated annonce la démission de Carrie Eglinton Manner en tant q..
More news
Analyst Recommendations on QUEST DIAGNOSTICS
More recommendations
Chart QUEST DIAGNOSTICS
Duration : Period :
Quest Diagnostics Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QUEST DIAGNOSTICS
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Last Close Price 140,31 $
Average target price 148,79 $
Spread / Average Target 6,04%
EPS Revisions
Managers and Directors
Stephen H. Rusckowski Chairman, President & Chief Executive Officer
James E. Davis Senior Vice President-Diagnostics Solutions
Mark J. Guinan Chief Financial Officer & Executive Vice President
Jay G. Wohlgemuth Chief Medical Officer, Senior VP-R&D, Medical
Gabrielle Wolfson SVP, Chief Information & Digital Officer
Sector and Competitors
1st jan.Capi. (M$)
QUEST DIAGNOSTICS-18.90%16 467
CVS HEALTH CORPORATION-8.38%123 945
HCA HEALTHCARE, INC.-29.03%53 876
LABORATORY CORPORATION OF AMERICA HOLDINGS-22.80%22 485
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY23.17%18 281
FRESENIUS MEDICAL CARE AG & CO. KGAA-17.59%14 556